Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
Anthony A. Fodor, Mark Pimentel, William D. Chey, et al.
Gut Microbes (2018) Vol. 10, Iss. 1, pp. 22-33
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Brian E. Lacy, Mark Pimentel, Darren M. Brenner, et al.
The American Journal of Gastroenterology (2020) Vol. 116, Iss. 1, pp. 17-44
Open Access | Times Cited: 572
The Gut–Brain Axis
Emeran A. Mayer, Karina Nance, Shelley Chen
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 439-453
Open Access | Times Cited: 459
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 91
Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review
Sofia D. Shaikh, Natalie Sun, Andrew Canakis, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2558-2558
Open Access | Times Cited: 74
The gut microbiome and irritable bowel syndrome
Stacy B. Menees, William D. Chey
F1000Research (2018) Vol. 7, pp. 1029-1029
Open Access | Times Cited: 134
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
Will Takakura, Mark Pimentel
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 129
The challenges of primary biliary cholangitis: What is new and what needs to be done
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani, et al.
Journal of Autoimmunity (2019) Vol. 105, pp. 102328-102328
Open Access | Times Cited: 106
No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population
Luisa W. Hugerth, Anna Andréasson, Nicholas J. Talley, et al.
Gut (2019) Vol. 69, Iss. 6, pp. 1076-1084
Open Access | Times Cited: 93
Irritable bowel syndrome and gut microbiota
Andrew Canakis, Mustafa Haroon, H. Christian Weber
Current Opinion in Endocrinology Diabetes and Obesity (2019) Vol. 27, Iss. 1, pp. 28-35
Closed Access | Times Cited: 92
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
Caterina Carco, Wayne Young, Richard B. Gearry, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 80
Irritable bowel syndrome: treatment based on pathophysiology and biomarkers
Michael Camilleri, Guy E. Boeckxstaens
Gut (2022) Vol. 72, Iss. 3, pp. 590-599
Closed Access | Times Cited: 59
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2369-2369
Open Access | Times Cited: 33
Assessing the relationship between gut microbiota and irritable bowel syndrome: a two-sample Mendelian randomization analysis
Bin Liu, Ding Ye, Hong Yang, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Understanding Our Tests: Hydrogen-Methane Breath Testing to Diagnose Small Intestinal Bacterial Overgrowth
Aylin Tansel, David J. Levinthal
Clinical and Translational Gastroenterology (2023)
Open Access | Times Cited: 29
Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review
Noemi Salmeri, Emanuele Sinagra, Carolina Dolci, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2089-2089
Open Access | Times Cited: 25
Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis
Will Takakura, Ali Rezaie, William D. Chey, et al.
Journal of Neurogastroenterology and Motility (2024) Vol. 30, Iss. 1, pp. 7-16
Open Access | Times Cited: 15
Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions
David J. Cangemi, Brian E. Lacy
Therapeutic Advances in Gastroenterology (2019) Vol. 12
Open Access | Times Cited: 70
Actinomycete-Derived Polyketides as a Source of Antibiotics and Lead Structures for the Development of New Antimicrobial Drugs
Helene Lunde Robertsen, Ewa Maria Musiol-Kroll
Antibiotics (2019) Vol. 8, Iss. 4, pp. 157-157
Open Access | Times Cited: 68
Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
Ali Rezaie, Zeev Heimanson, Richard W. McCallum, et al.
The American Journal of Gastroenterology (2019) Vol. 114, Iss. 12, pp. 1886-1893
Open Access | Times Cited: 68
Effect of antibiotics on the human microbiome: a systematic review
Kristien Nel Van Zyl, Siphiwe R. Matukane, Bianca Hamman, et al.
International Journal of Antimicrobial Agents (2021) Vol. 59, Iss. 2, pp. 106502-106502
Closed Access | Times Cited: 53
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Lijun Mei, Jiaoli Zhou, Yimo Su, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Emerging trends and focus of human gastrointestinal microbiome research from 2010–2021: a visualized study
Xingzhu Yuan, Chengting Chang, Xinrong Chen, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea
Darren M. Brenner, Gregory S. Sayuk
Advances in Therapy (2019) Vol. 37, Iss. 1, pp. 83-96
Open Access | Times Cited: 47
Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review
William D. Chey, Eric D. Shah, Herbert L. DuPont
Therapeutic Advances in Gastroenterology (2020) Vol. 13
Open Access | Times Cited: 40
Irritable bowel syndrome: diagnosis and management
Imke Masuy, Jasper Pannemans, Jan Tack
Minerva Gastroenterologica e Dietologica (2020) Vol. 66, Iss. 2
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top